Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jun;45(6):1799-802.
doi: 10.1128/AAC.45.6.1799-1802.2001.

Resistance studies with daptomycin

Affiliations

Resistance studies with daptomycin

J A Silverman et al. Antimicrob Agents Chemother. 2001 Jun.

Abstract

We studied the in vitro emergence of resistance to daptomycin using three methods: spontaneous resistance incidence, serial passage in the presence of increasing drug concentrations, and chemical mutagenesis. No spontaneously resistant mutants were obtained for any organism tested (<10(-10) for Staphylococcus aureus, <10(-9) for Staphylococcus epidermidis, <10(-9) for Enterococcus faecalis, <10(-9) for Enterococcus faecium, <10(-8) for Streptococcus pneumoniae). Population analysis demonstrated that bacterial susceptibility to daptomycin is heterogeneous. Assay results were sensitive to calcium concentration and culture density, both of which can affect apparent resistance rates. Stable S. aureus mutants were isolated by both serial passage in liquid media and chemical mutagenesis. The daptomycin MICs for these isolates were 8- to 32-fold higher than for the parental strain. Many mutants with high MICs (>12.5 microg/ml) had significant growth defects but did not display phenotypes typical of S. aureus small colony variants. The voltage component (Delta psi) of the bacterial membrane potential was increased in three independent resistant isolates. In vivo data showed that some daptomycin-resistant mutants had lost significant virulence. For other mutants, the degree of in vitro resistance was greater than the change in in vivo susceptibility. These results suggest that infection with some daptomycin-resistant organisms may still be easily treatable.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Susceptibility to daptomycin is heterogeneous in S. aureus. (A) Susceptibility is heterogeneous in both laboratory (Sa42) and clinical (Sa675) isolates (●, Sa42; ○, Sa675). Data are mean values ± the standard deviation. (B) Heterogeneous susceptibility in Sa42 is affected by calcium (○, MHA [MIC = 1 μg/ml]; ●, MHA plus 50 mg of Ca2+ per liter [MIC = 0.3 μg/ml]). Data are mean values ± the standard deviation. (C) Heterogeneous susceptibility is observed in daptomycin-resistant mutants (□, Sa42 [parent]; ■, Sa278 [class 1]; ○, Sa295 [class 2]; ●, Sa291 [class 3]). Representative data are shown.

References

    1. Alborn W E, Jr, Allen N E, Preston D A. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother. 1991;35:2282–2287. - PMC - PubMed
    1. Allen N E, Alborn W E, Jr, Hobbs J N., Jr Inhibition of membrane potential-dependent amino acid transport by daptomycin. Antimicrob Agents Chemother. 1991;35:2639–2642. - PMC - PubMed
    1. Boaretti M, Canepari P. Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae. Antimicrob Agents Chemother. 1995;39:2068–2072. - PMC - PubMed
    1. Boaretti M, Canepari P, del Mar Lleò M, Satta G. The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis. J Antimicrob Chemother. 1993;31:227–235. - PubMed
    1. Canepari P, Boaretti M, del Mar Lleó M, Satta G. Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032) Antimicrob Agents Chemother. 1990;34:1220–1226. - PMC - PubMed